 |
市场调查报告书
商品编码
1547835
全球噬菌体治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测Global Bacteriophage Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
||||||
全球噬菌体治疗市场需求预计将从 2023 年的 4,739 万美元增至 2032 年的近 7,428 万美元，2024-2032 年研究期间复合年增长率为 5.12%。
噬菌体疗法或噬菌体疗法利用噬菌体来治疗细菌感染。噬菌体或噬菌体是一种附着在细菌细胞上并将病毒基因组或 DNA 注入细菌细胞的病毒。病毒基因组取代细菌基因组，最终阻止细菌进一步生长和感染。具有病毒基因组的细菌细胞复製噬菌体。噬菌体与抗生素相比，两者都能有效杀死引起感染的细菌。然而，噬菌体的作用比抗生素更具特异性。它们不会损害宿主细胞以及其他有益细菌，例如宿主体内的肠道菌丛。噬菌体是抗生素的替代疗法，因为许多传染性细菌现在对常用的广谱抗生素产生了抗药性。
市场动态
推动全球噬菌体市场的因素是空气、水和食源性细菌感染的日益流行，以及抗生素抗药性发生率的增加。此外，噬菌体疗法的副作用几乎为零或很少。这项因素正在支撑全球市场。此外，私营部门和政府部门对噬菌体疗法的广泛研发进一步推动了全球市场的发展。在 COVID-19 大流行期间，噬菌体治疗市场可能会扩大，因为整个全球的焦点都集中在开发新的感染治疗疗法。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球噬菌体治疗市场的每个细分市场进行了包容性评估。噬菌体治疗产业的成长和趋势为本研究提供了整体方法。
市场区隔
噬菌体治疗市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。
按产品分类
- 噬菌体益生菌
- 噬菌体治疗
依给药途径
- 口服
- 专题
按申请
- 皮肤感染治疗
- 胃肠病学
- 伤口预防
- 呼吸道感染治疗
- 泌尿生殖感染治疗
区域分析
本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲噬菌体治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。噬菌体治疗市场的主要参与者包括 PhagePro Inc.、Enbiotix Inc.、TechnoPhage SA、Eligo Bioscience SA、Armata Pharmaceuticals Inc.、ContraFect Corporation、Phagomed Biopharma GmbH.、Eliava Biopreparations Ltd.、Fixed-Phage Ltd.、Intodeworld Inc. ., Pherecydes Pharma, BiomX Ltd., Adaptive Phage Therapeutics, Intralytix Inc., Phagelux Inc. 本部分包含竞争格局的整体视图，其中包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发布和其他开发。
如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
目录
第一章：前言
- 报告说明
- 客观的
- 目标受众
- 独特的销售主张 (USP) 和产品
- 研究范围
- 研究方法
- 市场研究过程
- 市场研究方法论
第 2 章：执行摘要
- 市集亮点
- 全球市场概况
第 3 章：噬菌体疗法 - 产业分析
- 简介 - 市场动态
- 市场驱动因素
- 市场限制
- 机会
- 产业动态
- 波特五力分析
- 市场吸引力分析
- 按产品分類的市场吸引力分析
- 按给药途径进行的市场吸引力分析
- 市场吸引力分析：依应用分类
- 市场吸引力分析：按地区
第 4 章：价值链分析
- 价值链分析
- 原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
- 潜在买家名单
- 行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势
第 5 章：全球噬菌体治疗市场分析：按产品
- 概述（按产品）
- 历史和预测数据
- 按产品分析
- 噬菌体益生菌
- 噬菌体治疗
第 6 章：全球噬菌体治疗市场分析：依给药途径
- 依给药途径概述
- 历史和预测数据
- 依给药途径分析
- 口服
- 专题
第 7 章：全球噬菌体治疗市场分析：依应用分类
- 概述：按应用
- 历史和预测数据
- 分析：按应用
- 皮肤感染治疗
- 胃肠病学
- 伤口预防
- 呼吸道感染治疗
- 泌尿生殖感染治疗
第 8 章：全球噬菌体治疗市场分析：依地理位置
- 区域展望
- 介绍
- 北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
- 欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
- 亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
- 拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
- 中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析
第 9 章：噬菌体治疗公司的竞争格局
- 噬菌体治疗市场竞争
- 伙伴关係/协作/协议
- 併购
- 新产品发布
- 其他发展
第 10 章：公司简介
- 顶级公司市占率分析
- 市场集中度
- PhagePro Inc.
- 公司概况
- 公司收入
- 产品
- 最新动态
- Enbiotix Inc.
- 公司概况
- 公司收入
- 产品
- 最新动态
- TechnoPhage SA
- 公司概况
- 公司收入
- 产品
- 最新动态
- Eligo Bioscience SA
- 公司概况
- 公司收入
- 产品
- 最新动态
- Armata Pharmaceuticals Inc.
- 公司概况
- 公司收入
- 产品
- 最新动态
- ContraFect Corporation
- 公司概况
- 公司收入
- 产品
- 最新动态
- Phagomed Biopharma GmbH.
- 公司概况
- 公司收入
- 产品
- 最新动态
- Eliava Biopreparations Ltd.
- 公司概况
- 公司收入
- 产品
- 最新动态
- Fixed-Phage Ltd.
- 公司概况
- 公司收入
- 产品
- 最新动态
- Intodeworld Inc.
- 公司概况
- 公司收入
- 产品
- 最新动态
- Pherecydes Pharma
- 公司概况
- 公司收入
- 产品
- 最新动态
- BiomX Ltd.
- 公司概况
- 公司收入
- 产品
- 最新动态
- Adaptive Phage Therapeutics
- 公司概况
- 公司收入
- 产品
- 最新动态
- Intralytix Inc.
- 公司概况
- 公司收入
- 产品
- 最新动态
- Phagelux Inc
- 公司概况
- 公司收入
- 产品
- 最新动态
註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内
The global demand for Bacteriophage Therapy Market is presumed to reach the market size of nearly USD 74.28 Million by 2032 from USD 47.39 Million in 2023 with a CAGR of 5.12% under the study period 2024-2032.
Bacteriophage therapy or phage therapy utilizes bacteriophages to treat bacterial infections. Bacteriophage or phage is the type of virus that gets attached to the bacterial cell and injects viral genome or DNA into the bacterial cell. The viral genome takes the place of the bacterial genome and eventually stops further bacterial growth and infection. The bacterial cell with viral genome replicates bacteriophages. Bacteriophages are compared with antibiotics as both effectively kill infection-causing bacteria; however, bacteriophages are more specific in action than antibiotics. They do not harm host cells as well as to other beneficial bacteria such as gut flora in the host body. Bacteriophages are an alternative therapy to antibiotics as many infectious bacteria are now resistant to the regularly used broad-spectrum antibiotics.
MARKET DYNAMICS
The factors that are driving the global bacteriophage market are the increasing prevalence of air, water, and foodborne bacterial infection, and increasing incidences of antibiotic resistance. Besides, there are almost nil or few side effects of bacteriophage therapy. This factor is supporting the global market. Moreover, extensive R & D on bacteriophage therapy by private as well as government sectors is further fuelling the global market. During the COVID-19 pandemic, the bacteriophage therapy market is likely to expand as the entire global focus is on the development of new treatment therapies for infections.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Bacteriophage Therapy. The growth and trends of Bacteriophage Therapy industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Bacteriophage Therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
- Phage Probiotics
- Phage Therapeutic
By Route of Administration
- Oral
- Topical
By Application
- Skin Infection Treatment
- Gastroenterology
- Wound Prophylaxis
- Respiratory Infections Treatment
- Urogenital Infection Treatment
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Bacteriophage Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Bacteriophage Therapy market include PhagePro Inc., Enbiotix Inc., TechnoPhage SA, Eligo Bioscience SA, Armata Pharmaceuticals Inc., ContraFect Corporation, Phagomed Biopharma GmbH., Eliava Biopreparations Ltd., Fixed-Phage Ltd., Intodeworld Inc., Pherecydes Pharma, BiomX Ltd., Adaptive Phage Therapeutics, Intralytix Inc., Phagelux Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1. PREFACE
- 1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3. BACTERIOPHAGE THERAPY - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Route of Administration
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend
5. GLOBAL BACTERIOPHAGE THERAPY MARKET ANALYSIS BY PRODUCT
- 5.1. Overview By Product
- 5.2. Historical and Forecast Data
- 5.3. Analysis By Product
- 5.4. Phage Probiotics Historic and Forecast Sales By Regions
- 5.5. Phage Therapeutic Historic and Forecast Sales By Regions
6. GLOBAL BACTERIOPHAGE THERAPY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
- 6.1. Overview By Route of Administration
- 6.2. Historical and Forecast Data
- 6.3. Analysis By Route of Administration
- 6.4. Oral Historic and Forecast Sales By Regions
- 6.5. Topical Historic and Forecast Sales By Regions
7. GLOBAL BACTERIOPHAGE THERAPY MARKET ANALYSIS BY APPLICATION
- 7.1. Overview By Application
- 7.2. Historical and Forecast Data
- 7.3. Analysis By Application
- 7.4. Skin Infection Treatment Historic and Forecast Sales By Regions
- 7.5. Gastroenterology Historic and Forecast Sales By Regions
- 7.6. Wound Prophylaxis Historic and Forecast Sales By Regions
- 7.7. Respiratory Infections Treatment Historic and Forecast Sales By Regions
- 7.8. Urogenital Infection Treatment Historic and Forecast Sales By Regions
8. GLOBAL BACTERIOPHAGE THERAPY MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis
9. COMPETITIVE LANDSCAPE OF THE BACTERIOPHAGE THERAPY COMPANIES
- 9.1. Bacteriophage Therapy Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10. COMPANY PROFILES OF BACTERIOPHAGE THERAPY INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Market Concentration Rate
- 10.3. PhagePro Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
- 10.4. Enbiotix Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
- 10.5. TechnoPhage SA
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
- 10.6. Eligo Bioscience SA
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
- 10.7. Armata Pharmaceuticals Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
- 10.8. ContraFect Corporation
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
- 10.9. Phagomed Biopharma GmbH.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
- 10.10. Eliava Biopreparations Ltd.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
- 10.11. Fixed-Phage Ltd.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
- 10.12. Intodeworld Inc.
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
- 10.13. Pherecydes Pharma
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
- 10.14. BiomX Ltd.
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
- 10.15. Adaptive Phage Therapeutics
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments
- 10.16. Intralytix Inc.
- 10.16.1 Company Overview
- 10.16.2 Company Revenue
- 10.16.3 Products
- 10.16.4 Recent Developments
- 10.17. Phagelux Inc
- 10.17.1 Company Overview
- 10.17.2 Company Revenue
- 10.17.3 Products
- 10.17.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers: Impact Analysis
- Restraints: Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- Analysis By Product (USD MN)
- Phage Probiotics Market Sales By Geography (USD MN)
- Phage Therapeutic Market Sales By Geography (USD MN)
- Analysis By Route of Administration (USD MN)
- Oral Market Sales By Geography (USD MN)
- Topical Market Sales By Geography (USD MN)
- Analysis By Application (USD MN)
- Skin Infection Treatment Market Sales By Geography (USD MN)
- Gastroenterology Market Sales By Geography (USD MN)
- Wound Prophylaxis Market Sales By Geography (USD MN)
- Respiratory Infections Treatment Market Sales By Geography (USD MN)
- Urogenital Infection Treatment Market Sales By Geography (USD MN)
- Global Bacteriophage Therapy Market Sales By Geography (USD MN)
- North America Market Analysis (USD MN)
- United States Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate By Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Bacteriophage Therapy Report
- Market Research Process
- Market Research Methodology
- Global Bacteriophage Therapy Market Size, By Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis By Product
- Market Attractiveness Analysis By Route of Administration
- Market Attractiveness Analysis By Application
- Market Attractiveness Analysis By Region
- Value Chain Analysis
- Global Market Analysis By Product (USD MN)
- Phage Probiotics Market Sales By Geography (USD MN)
- Phage Therapeutic Market Sales By Geography (USD MN)
- Global Market Analysis By Route of Administration (USD MN)
- Oral Market Sales By Geography (USD MN)
- Topical Market Sales By Geography (USD MN)
- Global Market Analysis By Application (USD MN)
- Skin Infection Treatment Market Sales By Geography (USD MN)
- Gastroenterology Market Sales By Geography (USD MN)
- Wound Prophylaxis Market Sales By Geography (USD MN)
- Respiratory Infections Treatment Market Sales By Geography (USD MN)
- Urogenital Infection Treatment Market Sales By Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
